BEVACIZUMAB

BEVACIZUMAB was reported 125242 times

These side effects are most commonly reported by patients taking BEVACIZUMAB:

# Side effect Count
0 OFF LABEL USE 14881
1 DEATH 13305
2 DIARRHOEA 7454
3 DISEASE PROGRESSION 7448
4 FATIGUE 6621
5 NAUSEA 6613
6 HYPERTENSION 5933
7 VOMITING 5028
8 ANAEMIA 4504
9 PYREXIA 4134
10 NEUTROPENIA 4091
11 ASTHENIA 3623
12 DECREASED APPETITE 3524
13 DYSPNOEA 3466
14 THROMBOCYTOPENIA 3453
15 DRUG INEFFECTIVE 3323
16 PROTEINURIA 3147
17 NEUROPATHY PERIPHERAL 3137
18 ABDOMINAL PAIN 2905
19 MALIGNANT NEOPLASM PROGRESSION 2817
20 RASH 2426
21 CONSTIPATION 2386
22 HEADACHE 2377
23 PAIN 2339
24 NO ADVERSE EVENT 2320
25 MYELOSUPPRESSION 2304
26 PLATELET COUNT DECREASED 2296
27 INTENTIONAL PRODUCT USE ISSUE 2227
28 FEBRILE NEUTROPENIA 2196
29 EPISTAXIS 2160
30 PNEUMONIA 2037
31 DEHYDRATION 2035
32 PULMONARY EMBOLISM 2027
33 WEIGHT DECREASED 2002
34 GENERAL PHYSICAL HEALTH DETERIORATION 1901
35 WHITE BLOOD CELL COUNT DECREASED 1816
36 MALAISE 1789
37 NEUTROPHIL COUNT DECREASED 1693
38 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1631
39 ASCITES 1564
40 SEPSIS 1550
41 STOMATITIS 1506
42 LEUKOPENIA 1493
43 COUGH 1439
44 HAEMORRHAGE 1420
45 DIZZINESS 1417
46 ARTHRALGIA 1408
47 BLOOD PRESSURE INCREASED 1399
48 MUCOSAL INFLAMMATION 1378
49 INTERSTITIAL LUNG DISEASE 1359
50 PLEURAL EFFUSION 1303
51 INFECTION 1279
52 ALOPECIA 1268
53 NEOPLASM PROGRESSION 1250
54 BACK PAIN 1249
55 DEEP VEIN THROMBOSIS 1246
56 VISUAL IMPAIRMENT 1241
57 ENDOPHTHALMITIS 1233
58 HAEMOGLOBIN DECREASED 1192
59 HYPOTENSION 1163
60 URINARY TRACT INFECTION 1160
61 METASTASES TO LIVER 1149
62 ACUTE KIDNEY INJURY 1143
63 BLINDNESS 1115
64 GASTROINTESTINAL PERFORATION 1099
65 FALL 1046
66 INTESTINAL OBSTRUCTION 1046
67 RENAL IMPAIRMENT 1033
68 CHEST PAIN 1025
69 CONFUSIONAL STATE 1014
70 BONE MARROW FAILURE 1011
71 RENAL FAILURE 1011
72 PRURITUS 1005
73 CEREBROVASCULAR ACCIDENT 1003
74 HEPATIC FUNCTION ABNORMAL 998
75 ALANINE AMINOTRANSFERASE INCREASED 987
76 PAIN IN EXTREMITY 979
77 ASPARTATE AMINOTRANSFERASE INCREASED 969
78 THERAPY PARTIAL RESPONDER 969
79 HYPERSENSITIVITY 962
80 HYPOKALAEMIA 962
81 INTESTINAL PERFORATION 961
82 OEDEMA PERIPHERAL 929
83 ABDOMINAL PAIN UPPER 913
84 BLOOD CREATININE INCREASED 911
85 ERYTHEMA 909
86 PARAESTHESIA 893
87 GASTROINTESTINAL HAEMORRHAGE 892
88 HYPOTHYROIDISM 883
89 THROMBOSIS 877
90 HYPONATRAEMIA 874
91 CARDIAC FAILURE 860
92 HYPOAESTHESIA 857
93 HEPATIC FAILURE 850
94 METASTASES TO LUNG 846
95 CONDITION AGGRAVATED 838
96 VISUAL ACUITY REDUCED 835
97 TOXICITY TO VARIOUS AGENTS 815
98 HEPATOCELLULAR CARCINOMA 809
99 COLITIS 797
100 VISION BLURRED 781
101 PRODUCT USE IN UNAPPROVED INDICATION 780
102 NEUROTOXICITY 772
103 PNEUMONITIS 751
104 CHILLS 741
105 MYOCARDIAL INFARCTION 731
106 PANCYTOPENIA 727
107 GASTROINTESTINAL DISORDER 725
108 RESPIRATORY FAILURE 725
109 MUSCULAR WEAKNESS 711
110 DYSPHONIA 706
111 ATRIAL FIBRILLATION 705
112 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 686
113 DYSPHAGIA 686
114 HAEMOPTYSIS 670
115 LARGE INTESTINE PERFORATION 658
116 INSOMNIA 654
117 MYALGIA 653
118 PRODUCT USE ISSUE 649
119 METASTASES TO BONE 647
120 ANXIETY 645
121 TACHYCARDIA 642
122 BLOOD BILIRUBIN INCREASED 638
123 SEIZURE 637
124 IMPAIRED HEALING 626
125 INFUSION RELATED REACTION 615
126 PERITONITIS 615
127 METASTASES TO CENTRAL NERVOUS SYSTEM 613
128 GAIT DISTURBANCE 605
129 SYNCOPE 605
130 COLORECTAL CANCER METASTATIC 597
131 OSTEONECROSIS OF JAW 597
132 SEPTIC SHOCK 597
133 NEOPLASM MALIGNANT 580
134 RECTAL HAEMORRHAGE 576
135 NASOPHARYNGITIS 573
136 EMBOLISM 553
137 ABDOMINAL DISTENSION 551
138 ILEUS 526
139 CATARACT 525
140 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 524
141 PNEUMOTHORAX 520
142 EYE PAIN 519
143 CONVULSION 512
144 OEDEMA 506
145 PERIPHERAL SENSORY NEUROPATHY 496
146 POLYNEUROPATHY 491
147 DEPRESSION 489
148 SMALL INTESTINAL OBSTRUCTION 489
149 LIVER DISORDER 484
150 HAEMATOTOXICITY 480
151 HAEMATURIA 480
152 THROMBOTIC MICROANGIOPATHY 478
153 RENAL FAILURE ACUTE 472
154 SOMNOLENCE 471
155 DRY SKIN 470
156 DRUG INTOLERANCE 468
157 ILL-DEFINED DISORDER 455
158 CEREBRAL HAEMORRHAGE 452
159 ABDOMINAL DISCOMFORT 449
160 DRUG HYPERSENSITIVITY 441
161 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 440
162 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 439
163 CARDIAC ARREST 434
164 VITREOUS FLOATERS 434
165 WEIGHT INCREASED 434
166 DYSGEUSIA 427
167 ADRENAL INSUFFICIENCY 421
168 DRUG RESISTANCE 420
169 HYPOXIA 420
170 DISSEMINATED INTRAVASCULAR COAGULATION 419
171 RETINAL HAEMORRHAGE 418
172 DYSPEPSIA 413
173 PROTEIN URINE PRESENT 412
174 NEPHROTIC SYNDROME 411
175 LOSS OF CONSCIOUSNESS 408
176 CEREBRAL INFARCTION 407
177 HYPOMAGNESAEMIA 406
178 MUSCLE SPASMS 398
179 HYPERGLYCAEMIA 397
180 BONE PAIN 393
181 PANCREATITIS 389
182 LYMPHOCYTE COUNT DECREASED 385
183 EYE HAEMORRHAGE 382
184 MUSCULOSKELETAL PAIN 382
185 HYPERKALAEMIA 381
186 JAUNDICE 381
187 OROPHARYNGEAL PAIN 380
188 TRANSAMINASES INCREASED 379
189 OSTEONECROSIS 378
190 BLOOD ALKALINE PHOSPHATASE INCREASED 374
191 HYPERHIDROSIS 370
192 SKIN ULCER 370
193 CHEST DISCOMFORT 362
194 TUMOUR HAEMORRHAGE 356
195 HEPATITIS 355
196 LACRIMATION INCREASED 352
197 HYPERBILIRUBINAEMIA 351
198 HAEMATOCHEZIA 348
199 LUNG DISORDER 343
200 DISEASE RECURRENCE 341
201 FISTULA 341
202 LYMPHOPENIA 340
203 MACULAR OEDEMA 340
204 SKIN TOXICITY 339
205 HAEMATEMESIS 337
206 HEMIPARESIS 337
207 DYSPNOEA EXERTIONAL 336
208 LYMPHADENOPATHY 336
209 OXYGEN SATURATION DECREASED 335
210 TREATMENT FAILURE 334
211 COVID-19 333
212 FLUSHING 333
213 MENTAL STATUS CHANGES 330
214 RHINORRHOEA 330
215 SKIN DISORDER 330
216 TREMOR 330
217 UVEITIS 330
218 BALANCE DISORDER 327
219 METASTASIS 327
220 TRANSIENT ISCHAEMIC ATTACK 325
221 OVARIAN CANCER 324
222 HEPATIC CIRRHOSIS 323
223 CELLULITIS 322
224 ANAPHYLACTIC REACTION 320
225 HYPOALBUMINAEMIA 320
226 NEOPLASM 318
227 INTRAOCULAR PRESSURE INCREASED 317
228 RETINAL DETACHMENT 317
229 CONTUSION 316
230 METASTASES TO PERITONEUM 316
231 RED BLOOD CELL COUNT DECREASED 315
232 ENCEPHALOPATHY 314
233 METASTASES TO LYMPH NODES 314
234 APHASIA 313
235 CARDIAC FAILURE CONGESTIVE 313
236 GLIOBLASTOMA 310
237 WOUND DEHISCENCE 310
238 HEPATIC ENCEPHALOPATHY 308
239 OCULAR HYPERAEMIA 308
240 MYELODYSPLASTIC SYNDROME 306
241 LIVER INJURY 305
242 EJECTION FRACTION DECREASED 304
243 OESOPHAGITIS 303
244 PERIPHERAL SWELLING 302
245 ACUTE MYELOID LEUKAEMIA 301
246 HEART RATE INCREASED 301
247 DERMATITIS ACNEIFORM 300
248 MYOCARDITIS 300
249 THERAPY NON-RESPONDER 300
250 PERICARDIAL EFFUSION 299
251 OESOPHAGEAL VARICES HAEMORRHAGE 296
252 CARDIO-RESPIRATORY ARREST 295
253 GASTROINTESTINAL TOXICITY 295
254 HEPATIC ENZYME INCREASED 295
255 SPEECH DISORDER 295
256 HEPATOTOXICITY 294
257 C-REACTIVE PROTEIN INCREASED 293
258 DRY MOUTH 293
259 MEMORY IMPAIRMENT 293
260 HAEMATOCRIT DECREASED 292
261 MOUTH ULCERATION 292
262 BLOOD GLUCOSE INCREASED 290
263 HYDRONEPHROSIS 286
264 PULMONARY OEDEMA 286
265 VARICES OESOPHAGEAL 286
266 EYE IRRITATION 285
267 EYE DISORDER 284
268 DRUG INTERACTION 283
269 BLINDNESS UNILATERAL 282
270 GASTROOESOPHAGEAL REFLUX DISEASE 281
271 HYPERTENSIVE CRISIS 281
272 INFLAMMATION 278
273 FEELING ABNORMAL 274
274 BREAST CANCER METASTATIC 273
275 EPILEPSY 272
276 LETHARGY 271
277 PORTAL HYPERTENSION 271
278 DEVICE RELATED INFECTION 270
279 RENAL DISORDER 270
280 URTICARIA 269
281 DYSURIA 266
282 HYPOCALCAEMIA 265
283 MELAENA 265
284 GINGIVAL BLEEDING 264
285 SUDDEN DEATH 263
286 GAMMA-GLUTAMYLTRANSFERASE INCREASED 260
287 HERPES ZOSTER 260
288 HYPERTHYROIDISM 260
289 OVARIAN CANCER RECURRENT 260
290 SMALL INTESTINAL PERFORATION 260
291 ADVERSE EVENT 258
292 CARDIOMYOPATHY 258
293 SKIN EXFOLIATION 254
294 ISCHAEMIC STROKE 251
295 CARDIAC DISORDER 250
296 DISCOMFORT 249
297 PALPITATIONS 246
298 CHOLANGITIS 245
299 PRODUCTIVE COUGH 245
300 ANAPHYLACTIC SHOCK 244
301 NERVOUS SYSTEM DISORDER 244
302 GASTRIC ULCER 242
303 MULTIPLE ORGAN DYSFUNCTION SYNDROME 242
304 VITREOUS HAEMORRHAGE 241
305 ARRHYTHMIA 240
306 DIVERTICULITIS 238
307 PNEUMONIA ASPIRATION 238
308 EYE INFLAMMATION 237
309 VERTIGO 237
310 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 234
311 DIABETES MELLITUS 233
312 CHOLESTASIS 232
313 ENTEROCOLITIS 231
314 DYSARTHRIA 230
315 ENTERITIS 230
316 MYOSITIS 230
317 SWELLING 229
318 HYPOPHOSPHATAEMIA 228
319 WOUND INFECTION 228
320 SPLENOMEGALY 225
321 BREAST CANCER 224
322 DRUG-INDUCED LIVER INJURY 224
323 PULMONARY HAEMORRHAGE 224
324 SUBRETINAL FLUID 224
325 ACUTE MYOCARDIAL INFARCTION 223
326 DEPRESSED LEVEL OF CONSCIOUSNESS 223
327 BLOOD PRESSURE DECREASED 222
328 ARTHRITIS 221
329 COGNITIVE DISORDER 221
330 HYPOPHAGIA 221
331 LUNG INFECTION 221
332 ATELECTASIS 220
333 CARBOHYDRATE ANTIGEN 125 INCREASED 218
334 COMA 218
335 SINUSITIS 218
336 ORAL PAIN 217
337 RETINAL THICKENING 217
338 COLON CANCER 216
339 DRY EYE 216
340 GASTRITIS 215
341 CEREBRAL ISCHAEMIA 214
342 PRODUCT QUALITY ISSUE 212
343 RETINAL OEDEMA 212
344 CHOLECYSTITIS 210
345 METASTASES TO MENINGES 210
346 ABSCESS 209
347 UPPER GASTROINTESTINAL HAEMORRHAGE 209
348 CARDIOTOXICITY 208
349 BRONCHITIS 207
350 HAEMORRHOIDS 207
351 BLOOD POTASSIUM DECREASED 206
352 PULMONARY MASS 206
353 THERAPEUTIC RESPONSE DECREASED 206
354 UPPER RESPIRATORY TRACT INFECTION 201
355 ACUTE RESPIRATORY DISTRESS SYNDROME 200
356 METASTATIC NEOPLASM 200
357 ALTERED STATE OF CONSCIOUSNESS 199
358 WHITE BLOOD CELL COUNT INCREASED 199
359 BRAIN OEDEMA 197
360 HAEMORRHAGE INTRACRANIAL 197
361 PORTAL VEIN THROMBOSIS 197
362 RASH MACULO-PAPULAR 197
363 TUMOUR NECROSIS 197
364 EMBOLISM VENOUS 196
365 EYE INFECTION 196
366 ACUTE CORONARY SYNDROME 195
367 LEFT VENTRICULAR DYSFUNCTION 195
368 NON-SMALL CELL LUNG CANCER 195
369 VENOUS THROMBOSIS 195
370 DERMATITIS 194
371 BLOOD LACTATE DEHYDROGENASE INCREASED 193
372 BRADYCARDIA 193
373 NECK PAIN 193
374 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 192
375 FEMALE GENITAL TRACT FISTULA 190
376 NEUTROPENIC SEPSIS 190
377 EYE PRURITUS 189
378 RESPIRATORY DISTRESS 188
379 THROAT TIGHTNESS 188
380 PANCREATITIS ACUTE 186
381 BODY TEMPERATURE INCREASED 185
382 COLON CANCER METASTATIC 185
383 PARONYCHIA 185
384 LEUKOCYTOSIS 183
385 SLEEP DISORDER 183
386 CYTOPENIA 182
387 MUSCULOSKELETAL CHEST PAIN 182
388 DUODENAL ULCER 181
389 BLOOD SODIUM DECREASED 180
390 INFLUENZA 179
391 MULTI-ORGAN FAILURE 179
392 TUMOUR MARKER INCREASED 179
393 LUNG NEOPLASM MALIGNANT 178
394 SHOCK 178
395 GLAUCOMA 177
396 URINARY RETENTION 177
397 CYSTITIS 176
398 FLATULENCE 176
399 AMNESIA 175
400 UNEVALUABLE EVENT 175
401 BACTERAEMIA 174
402 EYE DISCHARGE 174
403 TUMOUR LYSIS SYNDROME 174
404 BLOOD ALBUMIN DECREASED 173
405 DIPLOPIA 173
406 LIVER FUNCTION TEST ABNORMAL 173
407 PAIN IN JAW 173
408 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 172
409 HEPATIC LESION 172
410 INTERNATIONAL NORMALISED RATIO INCREASED 172
411 PULMONARY HYPERTENSION 172
412 ANAL FISTULA 171
413 FEELING HOT 171
414 ABDOMINAL PAIN LOWER 170
415 ANGINA PECTORIS 170
416 ENCEPHALITIS 170
417 CHOLELITHIASIS 168
418 HYPOGLYCAEMIA 168
419 INFLUENZA LIKE ILLNESS 168
420 DELIRIUM 167
421 LEUKOENCEPHALOPATHY 166
422 VENOOCCLUSIVE LIVER DISEASE 166
423 AGRANULOCYTOSIS 165
424 BLOOD PRESSURE SYSTOLIC INCREASED 165
425 GASTRIC PERFORATION 165
426 GASTROENTERITIS 164
427 IMMUNE-MEDIATED HEPATITIS 164
428 HAEMOLYTIC ANAEMIA 163
429 CYTOKINE RELEASE SYNDROME 162
430 MACULAR DEGENERATION 162
431 SHOCK HAEMORRHAGIC 162
432 ULCER 162
433 ELECTROLYTE IMBALANCE 161
434 MOBILITY DECREASED 160
435 THYROID DISORDER 160
436 ABDOMINAL ABSCESS 159
437 BLOOD UREA INCREASED 159
438 CARCINOEMBRYONIC ANTIGEN INCREASED 159
439 ERYTHEMA MULTIFORME 159
440 MYOCARDIAL ISCHAEMIA 159
441 DISORIENTATION 158
442 CHRONIC KIDNEY DISEASE 157
443 SINUS TACHYCARDIA 157
444 SUBILEUS 157
445 HICCUPS 156
446 RADIATION NECROSIS 156
447 NECROTISING FASCIITIS 155
448 CYSTOID MACULAR OEDEMA 153
449 MIGRAINE 153
450 VENTRICULAR FIBRILLATION 153
451 COLITIS ISCHAEMIC 152
452 PROCTALGIA 152
453 PROTEIN URINE 152
454 RASH ERYTHEMATOUS 152
455 HOT FLUSH 151
456 NEPHROPATHY TOXIC 151
457 ORAL CANDIDIASIS 151
458 ADVERSE DRUG REACTION 150
459 NEURALGIA 150
460 PRODUCT DOSE OMISSION ISSUE 150
461 ANOREXIA 148
462 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 148
463 CIRCULATORY COLLAPSE 148
464 HYPERAMMONAEMIA 148
465 ACUTE HEPATIC FAILURE 146
466 PHOTOPSIA 146
467 STAPHYLOCOCCAL INFECTION 146
468 BONE DISORDER 145
469 HEPATIC STEATOSIS 145
470 PERFORMANCE STATUS DECREASED 145
471 PRODUCT STORAGE ERROR 145
472 TASTE DISORDER 145
473 BLOOD URINE PRESENT 144
474 FRACTURE 144
475 BLOOD CREATINE PHOSPHOKINASE INCREASED 143
476 MUSCULOSKELETAL STIFFNESS 143
477 RESPIRATORY TRACT INFECTION 143
478 INTERCEPTED MEDICATION ERROR 142
479 MALNUTRITION 142
480 ACNE 141
481 ACUTE RESPIRATORY FAILURE 141
482 SUSPECTED OFF LABEL USE 141
483 EYE SWELLING 140
484 IMMUNE-MEDIATED ENTEROCOLITIS 140
485 RETINAL PIGMENT EPITHELIAL TEAR 140
486 ANASTOMOTIC LEAK 139
487 HAEMATOMA 139
488 OVERDOSE 139
489 PRODUCT COUNTERFEIT 139
490 DRUG ERUPTION 138
491 LUNG INFILTRATION 138
492 VITRITIS 138
493 ADENOCARCINOMA OF COLON 137
494 LUNG ADENOCARCINOMA 137
495 TUBULOINTERSTITIAL NEPHRITIS 137
496 HYPERCALCAEMIA 136
497 NAIL DISORDER 136
498 OSTEOARTHRITIS 136
499 URINARY INCONTINENCE 136
500 LOWER RESPIRATORY TRACT INFECTION 135
501 CHOLECYSTITIS ACUTE 134
502 POST PROCEDURAL COMPLICATION 134
503 PULMONARY FIBROSIS 134
504 PYELONEPHRITIS 134
505 SKIN DISCOLOURATION 134
506 AORTIC DISSECTION 133
507 ARTERIOSPASM CORONARY 133
508 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 133
509 AGE-RELATED MACULAR DEGENERATION 132
510 INTESTINAL ISCHAEMIA 132
511 MOVEMENT DISORDER 132
512 SECOND PRIMARY MALIGNANCY 132
513 TINNITUS 132
514 WHEEZING 132
515 BLISTER 131
516 COAGULOPATHY 131
517 RED CELL DISTRIBUTION WIDTH INCREASED 131
518 WOUND 131
519 ATAXIA 130
520 AZOTAEMIA 130
521 RECTAL PERFORATION 130
522 ASTHMA 129
523 ILLNESS 129
524 TOOTHACHE 129
525 VISUAL FIELD DEFECT 129
526 METASTASES TO SPINE 128
527 RESPIRATORY DISORDER 128
528 SUPRAVENTRICULAR TACHYCARDIA 128
529 SWELLING FACE 128
530 IMMUNE THROMBOCYTOPENIA 127
531 RASH PRURITIC 127
532 JOINT SWELLING 126
533 DEAFNESS 125
534 DUODENAL PERFORATION 125
535 HEPATIC CYTOLYSIS 125
536 VAGINAL HAEMORRHAGE 125
537 FEBRILE BONE MARROW APLASIA 124
538 FLANK PAIN 124
539 HEPATOCELLULAR INJURY 124
540 HYPERTRIGLYCERIDAEMIA 124
541 METABOLIC ACIDOSIS 124
542 NECROSIS 124
543 NO THERAPEUTIC RESPONSE 124
544 VIRAL INFECTION 124
545 BACTERIAL INFECTION 123
546 CACHEXIA 123
547 HYPERTRANSAMINASAEMIA 123
548 MEDICATION ERROR 123
549 SKIN FISSURES 123
550 GASTRIC HAEMORRHAGE 122
551 NASAL CONGESTION 121
552 NEUTROPHIL COUNT INCREASED 121
553 NODULE 121
554 FAILURE TO THRIVE 120
555 INTERCEPTED PRODUCT STORAGE ERROR 120
556 PULMONARY TOXICITY 120
557 TUMOUR PERFORATION 120
558 HEART RATE DECREASED 119
559 BRONCHOSPASM 118
560 LIVER FUNCTION TEST INCREASED 118
561 PHOTOPHOBIA 118
562 NIGHT SWEATS 117
563 PALLOR 117
564 PNEUMATOSIS INTESTINALIS 117
565 TYPE 1 DIABETES MELLITUS 117
566 BURNING SENSATION 116
567 INJECTION SITE PAIN 116
568 LARGE INTESTINAL OBSTRUCTION 116
569 MENINGITIS 116
570 POLLAKIURIA 115
571 SKIN REACTION 115
572 AGITATION 114
573 GASTROINTESTINAL NECROSIS 114
574 SUBARACHNOID HAEMORRHAGE 114
575 VITREOUS DETACHMENT 114
576 HEMIPLEGIA 113
577 OVARIAN CANCER METASTATIC 113
578 BODY TEMPERATURE DECREASED 112
579 HEPATITIS B REACTIVATION 112
580 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 112
581 MALIGNANT PLEURAL EFFUSION 112
582 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 112
583 PERFORATION 112
584 HALLUCINATION 111
585 HYPOACUSIS 111
586 CANDIDA INFECTION 110
587 FACE OEDEMA 110
588 GENERALISED OEDEMA 110
589 LOWER GASTROINTESTINAL HAEMORRHAGE 110
590 TEMPERATURE INTOLERANCE 110
591 RETINAL VEIN OCCLUSION 109
592 AUTOIMMUNE HEPATITIS 108
593 DIABETIC RETINAL OEDEMA 108
594 FEEDING DISORDER 108
595 LYMPHOEDEMA 108
596 OSTEOMYELITIS 108
597 RHABDOMYOLYSIS 108
598 HEPATIC ATROPHY 107
599 NEOPLASM RECURRENCE 107
600 TOOTH EXTRACTION 107
601 BLINDNESS TRANSIENT 106
602 NASAL SEPTUM PERFORATION 106
603 CORONARY ARTERY DISEASE 105
604 STEVENS-JOHNSON SYNDROME 105
605 NEPHROLITHIASIS 104
606 NEUTROPHIL COUNT ABNORMAL 104
607 BLOOD MAGNESIUM DECREASED 103
608 DEPRESSED MOOD 103
609 DIABETIC KETOACIDOSIS 103
610 ILEUS PARALYTIC 103
611 APHONIA 102
612 COLORECTAL CANCER 102
613 CONJUNCTIVITIS 102
614 METAMORPHOPSIA 102
615 STRESS 101
616 IRIDOCYCLITIS 100
617 PNEUMOCYSTIS JIROVECII PNEUMONIA 100
618 FUNGAL INFECTION 99
619 INJURY 99
620 MENTAL DISORDER 99
621 NEPHRITIS 99
622 THYROIDITIS 99
623 HYPERSOMNIA 98
624 RECURRENT CANCER 98
625 CARDIOVASCULAR DISORDER 97
626 DECUBITUS ULCER 97
627 IMMUNE-MEDIATED LUNG DISEASE 97
628 STRESS CARDIOMYOPATHY 97
629 VASCULITIS 97
630 ENTEROCUTANEOUS FISTULA 96
631 GLIOMA 96
632 HIP FRACTURE 96
633 LIVER ABSCESS 96
634 PELVIC PAIN 96
635 STOMA SITE HAEMORRHAGE 96
636 WOUND COMPLICATION 96
637 BLOOD TEST ABNORMAL 95
638 OCULAR DISCOMFORT 95
639 ORTHOSTATIC HYPOTENSION 95
640 RASH PUSTULAR 95
641 SKIN LESION 95
642 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 94
643 EYELID PTOSIS 94
644 HAEMORRHOIDAL HAEMORRHAGE 94
645 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 94
646 SKIN NECROSIS 94
647 VENOUS THROMBOSIS LIMB 94
648 FLUID RETENTION 93
649 GRANULOCYTE COUNT DECREASED 93
650 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 93
651 TOOTH ABSCESS 93
652 CYANOSIS 92
653 FEMUR FRACTURE 92
654 PERICARDITIS 92
655 SKIN HYPERPIGMENTATION 92
656 SURGERY 92
657 UROSEPSIS 92
658 BRAIN NEOPLASM 91
659 CONJUNCTIVAL HAEMORRHAGE 91
660 DIVERTICULAR PERFORATION 91
661 EMOTIONAL DISTRESS 91
662 GAIT INABILITY 91
663 HYDROCEPHALUS 91
664 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 91
665 LUNG NEOPLASM 91
666 PRESYNCOPE 91
667 RECTAL CANCER 91
668 THERAPEUTIC PRODUCT EFFECT DECREASED 91
669 THROMBOTIC THROMBOCYTOPENIC PURPURA 91
670 ANGIOPATHY 90
671 FAECALOMA 90
672 FAECES DISCOLOURED 90
673 GENE MUTATION 90
674 HAEMOGLOBIN ABNORMAL 90
675 LIPASE INCREASED 90
676 MITRAL VALVE INCOMPETENCE 90
677 AMYLASE INCREASED 89
678 BLOOD PRESSURE ABNORMAL 89
679 CLOSTRIDIUM DIFFICILE INFECTION 89
680 ASPIRATION 88
681 BLEEDING VARICOSE VEIN 88
682 BLOOD CHOLESTEROL INCREASED 88
683 IMMUNODEFICIENCY 88
684 OPTIC ISCHAEMIC NEUROPATHY 88
685 PELVIC ABSCESS 88
686 PHARYNGEAL OEDEMA 88
687 RENAL INJURY 88
688 TENDERNESS 88
689 ORAL HERPES 87
690 BACTERIAL ENDOPHTHALMITIS 86
691 BLOOD DISORDER 86
692 DRY THROAT 86
693 IMMUNE-MEDIATED ADVERSE REACTION 86
694 PHLEBITIS 86
695 RENAL CYST 86
696 ANAL FISSURE 85
697 EAR PAIN 85
698 GUILLAIN-BARRE SYNDROME 85
699 HYPERPYREXIA 85
700 HYPERTHERMIA 85
701 INTENTIONAL PRODUCT MISUSE 85
702 MEAN CELL VOLUME INCREASED 85
703 ODYNOPHAGIA 85
704 SPINAL OSTEOARTHRITIS 85
705 EMBOLISM ARTERIAL 84
706 HYPOVOLAEMIA 84
707 PERIPHERAL MOTOR NEUROPATHY 84
708 PNEUMOPERITONEUM 84
709 ANGIOEDEMA 83
710 ATRIAL FLUTTER 83
711 CARDIAC FAILURE ACUTE 83
712 ILEAL PERFORATION 83
713 ISCHAEMIA 83
714 LABORATORY TEST ABNORMAL 83
715 ORAL DISORDER 83
716 ABDOMINAL HERNIA 82
717 ACUTE PULMONARY OEDEMA 82
718 AUTOIMMUNE HAEMOLYTIC ANAEMIA 82
719 CATARACT NUCLEAR 82
720 DIARRHOEA HAEMORRHAGIC 82
721 ESCHERICHIA INFECTION 82
722 GLIOBLASTOMA MULTIFORME 82
723 METASTASES TO PLEURA 82
724 MYASTHENIA GRAVIS 82
725 ANAL ABSCESS 81
726 BLOOD THYROID STIMULATING HORMONE INCREASED 81
727 DRUG EFFECT DECREASED 81
728 INTERVERTEBRAL DISC PROTRUSION 81
729 PROCTITIS 81
730 EXTRAVASATION 80
731 HYPOPHYSITIS 80
732 MASS 80
733 PARALYSIS 80
734 PIGMENTATION DISORDER 80
735 PULMONARY THROMBOSIS 80
736 RENAL FAILURE CHRONIC 80
737 SENSORY DISTURBANCE 80
738 ABDOMINAL INFECTION 79
739 ARTERIAL THROMBOSIS 79
740 ARTHROPATHY 79
741 IRITIS 79
742 LYMPHADENOPATHY MEDIASTINAL 79
743 POST PROCEDURAL HAEMORRHAGE 79
744 RIB FRACTURE 79
745 SKIN INFECTION 79
746 BLOOD PRESSURE FLUCTUATION 78
747 GINGIVITIS 78
748 HOSPITALISATION 78
749 ADENOCARCINOMA 77
750 AGEUSIA 77
751 CONGESTIVE CARDIOMYOPATHY 77
752 INCORRECT DOSE ADMINISTERED 77
753 PETECHIAE 77
754 RESTLESSNESS 77
755 TACHYPNOEA 77
756 DERMATITIS BULLOUS 76
757 LYMPHANGIOSIS CARCINOMATOSA 76
758 RETINAL ARTERY OCCLUSION 76
759 TOXIC SKIN ERUPTION 76
760 UNDERDOSE 76
761 ABASIA 75
762 BLOOD CALCIUM DECREASED 75
763 BLOOD PRESSURE DIASTOLIC INCREASED 75
764 DRUG EFFECT INCOMPLETE 75
765 FEELING COLD 75
766 FULL BLOOD COUNT DECREASED 75
767 HEPATIC CANCER 75
768 IMMUNE SYSTEM DISORDER 75
769 MALIGNANT ASCITES 75
770 MICROANGIOPATHY 75
771 PERIPHERAL ISCHAEMIA 75
772 PSORIASIS 75
773 RHINITIS 75
774 THROAT IRRITATION 75
775 COLITIS ULCERATIVE 74
776 CYSTITIS HAEMORRHAGIC 74
777 JAUNDICE CHOLESTATIC 74
778 LIMB DISCOMFORT 74
779 PSEUDOCIRRHOSIS 74
780 RETINAL DISORDER 74
781 ARTERIOSCLEROSIS 73
782 DISTURBANCE IN ATTENTION 73
783 EMPHYSEMA 73
784 GRAND MAL CONVULSION 73
785 HYPERLIPIDAEMIA 73
786 NON-CARDIAC CHEST PAIN 73
787 PERIODONTITIS 73
788 TUMOUR RUPTURE 73
789 EATING DISORDER 72
790 GINGIVAL PAIN 72
791 RETINAL EXUDATES 72
792 VISUAL ACUITY TESTS ABNORMAL 72
793 ACQUIRED GENE MUTATION 71
794 DENTAL CARIES 71
795 HEPATIC NEOPLASM 71
796 KLEBSIELLA INFECTION 71
797 MACULAR HOLE 71
798 RETCHING 71
799 STATUS EPILEPTICUS 71
800 TOOTH DISORDER 71
801 ALANINE AMINOTRANSFERASE ABNORMAL 70
802 CHOROIDAL NEOVASCULARISATION 70
803 GASTRIC ULCER HAEMORRHAGE 70
804 LOCAL SWELLING 70
805 MOUTH HAEMORRHAGE 70
806 PATHOLOGICAL FRACTURE 70
807 PERIPHERAL COLDNESS 70
808 POOR QUALITY SLEEP 70
809 SUSPECTED COUNTERFEIT PRODUCT 70
810 TOOTH INFECTION 70
811 UROGENITAL FISTULA 70
812 APPENDICITIS 69
813 RENAL TUBULAR NECROSIS 69
814 CARDIAC DYSFUNCTION 68
815 FEMORAL NECK FRACTURE 68
816 FOURNIER^S GANGRENE 68
817 HYPERCHOLESTEROLAEMIA 68
818 NON-INFECTIOUS ENDOPHTHALMITIS 68
819 OCULAR HYPERTENSION 68
820 SCAR 68
821 SPINAL COMPRESSION FRACTURE 68
822 URINARY TRACT OBSTRUCTION 68
823 CORONARY ARTERY STENOSIS 67
824 PLATELET COUNT INCREASED 67
825 PURPURA 67
826 TREATMENT NONCOMPLIANCE 67
827 BONE LESION 66
828 CENTRAL NERVOUS SYSTEM LESION 66
829 DIABETIC RETINOPATHY 66
830 HAEMOLYSIS 66
831 HAEMOLYTIC URAEMIC SYNDROME 66
832 MUSCLE TWITCHING 66
833 ORAL INTAKE REDUCED 66
834 SINUS CONGESTION 66
835 ASPARTATE AMINOTRANSFERASE ABNORMAL 65
836 DYSAESTHESIA 65
837 ECCHYMOSIS 65
838 EMOTIONAL DISORDER 65
839 RESPIRATORY ARREST 65
840 ACUTE ABDOMEN 64
841 ANAL HAEMORRHAGE 64
842 BLOOD POTASSIUM INCREASED 64
843 EOSINOPHIL COUNT INCREASED 64
844 LOCALISED INFECTION 64
845 NEUROLOGICAL SYMPTOM 64
846 PRODUCT CONTAMINATION 64
847 RASH MACULAR 64
848 RETINAL DEGENERATION 64
849 VENA CAVA THROMBOSIS 64
850 CERVIX CARCINOMA 63
851 DRUG DOSE OMISSION 63
852 DRUG TOXICITY 63
853 DUODENAL ULCER HAEMORRHAGE 63
854 DUODENAL ULCER PERFORATION 63
855 ELECTROCARDIOGRAM QT PROLONGED 63
856 EXPOSED BONE IN JAW 63
857 JUGULAR VEIN THROMBOSIS 63
858 ORGANISING PNEUMONIA 63
859 THROMBOPHLEBITIS 63
860 TOOTH LOSS 63
861 TROPONIN INCREASED 63
862 VENTRICULAR TACHYCARDIA 63
863 ACIDOSIS 62
864 CANCER PAIN 62
865 CARDIOMEGALY 62
866 CHROMATURIA 62
867 FOLLICULITIS 62
868 GLOMERULONEPHRITIS 62
869 HEPATIC CYST 62
870 LIMB INJURY 62
871 MEAN CELL HAEMOGLOBIN INCREASED 62
872 RETINAL TEAR 62
873 UNRESPONSIVE TO STIMULI 62
874 ALPHA 1 FOETOPROTEIN INCREASED 61
875 AORTIC ANEURYSM 61
876 BLOOD COUNT ABNORMAL 61
877 CYTOMEGALOVIRUS INFECTION 61
878 FOREIGN BODY SENSATION IN EYES 61
879 GLOSSODYNIA 61
880 NEPHROPATHY 61
881 VASCULAR PSEUDOANEURYSM 61
882 APPETITE DISORDER 60
883 GASTROINTESTINAL INFLAMMATION 60
884 GRANULOCYTOPENIA 60
885 HEPATOMEGALY 60
886 HYPERAMMONAEMIC ENCEPHALOPATHY 60
887 MUSCULOSKELETAL DISCOMFORT 60
888 RECTAL ADENOCARCINOMA 60
889 SINUS DISORDER 60
890 SPINAL PAIN 60
891 SWOLLEN TONGUE 60
892 TOXIC ANTERIOR SEGMENT SYNDROME 60
893 ANASTOMOTIC COMPLICATION 59
894 APHTHOUS ULCER 59
895 CHOLANGITIS SCLEROSING 59
896 DEMENTIA 59
897 DIVERTICULUM INTESTINAL 59
898 GASTRIC DISORDER 59
899 LARYNGOSPASM 59
900 METASTASES TO SKIN 59
901 MYOPATHY 59
902 NON-SMALL CELL LUNG CANCER METASTATIC 59
903 OESOPHAGEAL ULCER 59
904 ONYCHOLYSIS 59
905 OSTEOPENIA 59
906 OSTEOPOROSIS 59
907 PAIN OF SKIN 59
908 SUBDURAL HAEMATOMA 59
909 TYPE 2 DIABETES MELLITUS 59
910 ABDOMINAL TENDERNESS 58
911 BILE DUCT STENOSIS 58
912 CARDIOGENIC SHOCK 58
913 CLOSTRIDIUM DIFFICILE COLITIS 58
914 EOSINOPHILIA 58
915 HEPATIC MASS 58
916 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 58
917 PERIRECTAL ABSCESS 58
918 RECTAL CANCER METASTATIC 58
919 ANAPHYLACTOID REACTION 57
920 ARRHYTHMIA SUPRAVENTRICULAR 57
921 BLOOD GLUCOSE DECREASED 57
922 CAPILLARY LEAK SYNDROME 57
923 GENERAL PHYSICAL CONDITION ABNORMAL 57
924 HAEMORRHAGIC STROKE 57
925 INTERNAL HAEMORRHAGE 57
926 NAIL DISCOLOURATION 57
927 OESOPHAGEAL CANDIDIASIS 57
928 PARTIAL SEIZURES 57
929 PERITONEAL DISORDER 57
930 PLEURISY 57
931 PROSTATE CANCER 57
932 ULCERATIVE KERATITIS 57
933 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57
934 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 56
935 AORTIC ARTERIOSCLEROSIS 56
936 GASTROINTESTINAL FISTULA 56
937 HYPOTHERMIA 56
938 IMMUNE THROMBOCYTOPENIC PURPURA 56
939 INCISIONAL HERNIA 56
940 INFECTIOUS PLEURAL EFFUSION 56
941 LARYNGITIS 56
942 RECTAL ULCER 56
943 SPINAL FRACTURE 56
944 TUMOUR PAIN 56
945 ABDOMINAL ADHESIONS 55
946 BONE MARROW TOXICITY 55
947 GASTROINTESTINAL ANASTOMOTIC LEAK 55
948 GASTROINTESTINAL PAIN 55
949 HERNIA 55
950 HYPOPITUITARISM 55
951 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 55
952 PROTHROMBIN TIME PROLONGED 55
953 SINUS BRADYCARDIA 55
954 TOXIC EPIDERMAL NECROLYSIS 55
955 ANEURYSM 54
956 BRAIN FOG 54
957 COLD SWEAT 54
958 DEVICE RELATED THROMBOSIS 54
959 HEPATIC PAIN 54
960 IMMUNE-MEDIATED HEPATIC DISORDER 54
961 TONGUE ULCERATION 54
962 VENTRICULAR HYPOKINESIA 54
963 BLOOD PRESSURE DIASTOLIC DECREASED 53
964 BREAST CANCER RECURRENT 53
965 COVID-19 PNEUMONIA 53
966 ENDOCARDITIS 53
967 GASTROINTESTINAL STOMA COMPLICATION 53
968 GLOMERULAR FILTRATION RATE DECREASED 53
969 HYPERURICAEMIA 53
970 HYPOVOLAEMIC SHOCK 53
971 MONOCYTE COUNT INCREASED 53
972 MULTIPLE-DRUG RESISTANCE 53
973 NEUTROPENIC INFECTION 53
974 NEUTROPHILIA 53
975 CHEILITIS 52
976 ENCEPHALITIS AUTOIMMUNE 52
977 HEART RATE IRREGULAR 52
978 INCORRECT PRODUCT STORAGE 52
979 LIP SWELLING 52
980 MACULAR FIBROSIS 52
981 METASTASES TO ADRENALS 52
982 OBESITY 52
983 OBSTRUCTIVE AIRWAYS DISORDER 52
984 PNEUMONIA BACTERIAL 52
985 POSTOPERATIVE WOUND INFECTION 52
986 THERAPY RESPONDER 52
987 ASPHYXIA 51
988 CHANGE OF BOWEL HABIT 51
989 DYSSTASIA 51
990 FREQUENT BOWEL MOVEMENTS 51
991 HEAD INJURY 51
992 METABOLIC DISORDER 51
993 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 51
994 WHITE BLOOD CELL COUNT ABNORMAL 51
995 BEDRIDDEN 50
996 BLOOD LACTIC ACID INCREASED 50
997 BONE MARROW DISORDER 50
998 BRAIN NEOPLASM MALIGNANT 50
999 BREATH SOUNDS ABNORMAL 50